Agree(ADC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ADC Agree

Pre-Mkt 10-08 09:14:34 EDT

65.16

-0.63

-0.96%

盘前65.78

+0.62+0.95%

08:59 EDT

High66.00	Low65.11	Vol1.45M
Open66.00	D1 Closing65.79	Amplitude1.35%
Mkt Cap8.10B	Tradable Cap7.96B	Total Shares124.38M
T/O94.54M	T/O Rate1.18%	Tradable Shares122.18M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ADC","market":"US","secType":"STK","nameCN":"Agree","latestPrice":65.16,"timestamp":1791403200000,"preClose":65.79,"halted":0,"volume":1445665,"hourTrading":{"tag":"盘前","latestPrice":65.78,"preClose":65.16,"latestTime":"08:59 EDT","volume":422,"amount":27584.97528,"timestamp":1791464368778,"change":0.62,"changeRate":0.009515,"amplitude":0.009822},"delay":0,"changeRate":-0.009575923392613005,"floatShares":122178283,"shares":124379300,"eps":1.85165,"marketStatus":"Pre-Mkt","change":-0.63,"latestTime":"10-08 09:14:34 EDT","open":66,"high":66,"low":65.11,"amount":94543498.47345,"amplitude":0.013528,"askPrice":66.66,"askSize":7,"bidPrice":65.18,"bidSize":193,"shortable":3,"etf":0,"ttmEps":1.85165,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791466200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":766296000000,"exchange":"NYSE","adjPreClose":65.16,"dividendRate":0.048204,"preHourTrading":{"tag":"盘前","latestPrice":65.78,"preClose":65.16,"latestTime":"08:59 EDT","volume":422,"amount":27584.97528,"timestamp":1791464368778,"change":0.62,"changeRate":0.009515,"amplitude":0.009822},"postHourTrading":{"tag":"盘后","latestPrice":65.84,"preClose":65.16,"latestTime":"19:53 EDT","volume":50683,"amount":3307808.6247,"timestamp":1791417222313,"change":0.68,"changeRate":0.010436,"amplitude":0.015735},"volumeRatio":0.7103977090941463,"impliedVol":0.2038,"impliedVolPercentile":0.2},"requestUrl":"/m/hq/s/ADC/wiki","defaultTab":"wiki","newsList":[{"id":"2673704061","title":"Crescent Biopharma Announces FDA Clearance of IND Application for CR-002, a PD-L1-targeted Topoisomerase Inhibitor ADC, for the Treatment of Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704061","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704061?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:30","pubTimestamp":1791199800,"startTime":"0","endTime":"0","summary":"Phase 1/2 APOLLO global clinical trial to evaluate CR-002 in multiple solid tumor types, including non-small cell lung cancer (NSCLC) and head and neck squamous cell carcinoma (HNSCC), on track to ini","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/05/3374436/0/en/crescent-biopharma-announces-fda-clearance-of-ind-application-for-cr-002-a-pd-l1-targeted-topoisomerase-inhibitor-adc-for-the-treatment-of-solid-tumors.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NETL","BK4080","BK4588","CR","LABU","BK4231","BK4585","ADC","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672923729","title":"Genmab Announces Rinatabart Sesutecan (Rina-S®) Phase 2 RAINFOL™-01 Results Demonstrated Durable and Clinically Meaningful Responses in Patients with Platinum-Resistant Ovarian Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2672923729","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672923729?lang=en_us&edition=fundamental","pubTime":"2026-10-04 03:40","pubTimestamp":1791056400,"startTime":"0","endTime":"0","summary":"Media Release COPENHAGEN, Denmark; October 3, 2026 Treatment with Rina-S 120 mg/m every three weeks demonstrated a clinically meaningful objective response rate (ORR) and durable median duration of re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/03/3374111/0/en/genmab-announces-rinatabart-sesutecan-rina-s-phase-2-rainfol-01-results-demonstrated-durable-and-clinically-meaningful-responses-in-patients-with-platinum-resistant-ovarian-cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2106854487.HKD","BK4231","LU2023250843.SGD","IE00BGHQF417.EUR","BK4086","IE00B2PGVK34.USD","LU2298321311.HKD","NETL","XHB","ORR","ADC","LU2092937221.SGD","LU0310800379.SGD","IE00B3CCJ633.GBP","PROC","LU1267930573.SGD","LU1974910355.USD","LU2023250504.SGD","LU2360108059.USD","LU0708994859.HKD","BK4007","OC","LU0128525929.USD","LU1917777945.USD","LU0868494617.USD","LU0029864427.USD","LU2041044095.USD","LU2048586759.USD","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672424017","title":"RBC Capital Reaffirms Their Buy Rating on Agree Realty (ADC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672424017","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672424017?lang=en_us&edition=fundamental","pubTime":"2026-10-03 09:45","pubTimestamp":1790991943,"startTime":"0","endTime":"0","summary":"In a report released on October 1, Brad Heffern from RBC Capital maintained a Buy rating on Agree Realty, with a price target of $73.00. The compan...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-reaffirms-their-buy-rating-on-agree-realty-adc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-reaffirms-their-buy-rating-on-agree-realty-adc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672747153","title":"Agree Realty (ADC) Stock Looks About Right After Its 38% 3 Year Gain","url":"https://stock-news.laohu8.com/highlight/detail?id=2672747153","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672747153?lang=en_us&edition=fundamental","pubTime":"2026-10-03 08:34","pubTimestamp":1790987694,"startTime":"0","endTime":"0","summary":"Agree Realty has delivered a 3 year gain that looks very different from its more muted shorter term returns, which puts a sharper spotlight on what investors are paying for each dollar of earnings today. With the share price recently closing at US$65.88 after a softer run over the past few weeks, the key issue is how well that tag lines up with the real estate landlord's profit power.\n\nThe stock is up 37.7% over 3 years, which makes it important to ask whether that rise is still grounded in...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551736-choice1-card/1788952954425","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551736-choice1-card/1788952954425"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-adc/agree-realty/news/agree-realty-adc-stock-looks-about-right-after-its-38-3-year","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-adc/agree-realty/news/agree-realty-adc-stock-looks-about-right-after-its-38-3-year","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DECU","BK4080","VGFPF","FEBU","NETL","BK4231","ADC","JOYT","VOTE","PMDE","GXDW","ADC.AU","BK7095","RGLO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672597719","title":"Pyxis Oncology Announces Closing of Up to $282.6 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2672597719","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672597719?lang=en_us&edition=fundamental","pubTime":"2026-10-02 19:00","pubTimestamp":1790938800,"startTime":"0","endTime":"0","summary":"BOSTON, Oct.  02, 2026 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS or the “Company”), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/02/3373740/0/en/pyxis-oncology-announces-closing-of-up-to-282-6-million-public-offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADC","BK4080","BK4231","PYXS","NETL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672762944","title":"Agree Realty (ADC) Gets a Buy from Truist Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2672762944","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672762944?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:35","pubTimestamp":1790886934,"startTime":"0","endTime":"0","summary":"In a report released today, Michael Lewis from Truist Financial maintained a Buy rating on Agree Realty, with a price target of $75.00. Lewis cover...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/agree-realty-adc-gets-a-buy-from-truist-financial-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/agree-realty-adc-gets-a-buy-from-truist-financial-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADC","BK4080","BK4231","NETL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672753881","title":"US Research Roundup-Amrize, Dexcom, Lennar","url":"https://stock-news.laohu8.com/highlight/detail?id=2672753881","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672753881?lang=en_us&edition=fundamental","pubTime":"2026-10-01 16:24","pubTimestamp":1790843060,"startTime":"0","endTime":"0","summary":"US RESEARCH ROUNDUP-Amrize, Dexcom, LennarOct 1 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several US-listed companies, including Amrize, Dexcom, and Lennar, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nL4N45N0J8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BAC","DKNG","APPS","DT","DXCM","CALM","AAPL","BX","CHCO","CMAG","DRAY","AMRZ","CAG","LITP","ATOS","CNTB","CVEO","BRO","DAL","DHI","ALB","DOW","ATO","CI","BJRI","CRH","CUBI","EKG","IDRV","SPTE","ADC","BXDC","BMRC","BOH","BANR","BANC","PRVT","KMX","ALL","LIMI","AAL","AXGN","AAPD","DKS","ABFL","CCL","CINF","CLX","CPG.UK","AIG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672731787","title":"Agree Realty Corporation : RBC Cuts Target Price to $73 from $82","url":"https://stock-news.laohu8.com/highlight/detail?id=2672731787","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672731787?lang=en_us&edition=fundamental","pubTime":"2026-10-01 12:40","pubTimestamp":1790829606,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45N0GO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4080","ADC","BK4231","NETL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672782804","title":"Agree Realty Schedules Third-Quarter Operating Results Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2672782804","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672782804?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:05","pubTimestamp":1790798747,"startTime":"0","endTime":"0","summary":"Agree Realty schedules third-quarter operating results conference callAgree Realty will report third-quarter 2026 results after the market close on Oct. 20, 2026.Management will host an earnings confe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL8MNNkg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NETL","BK4080","ADC","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672828457","title":"Agree Realty Announces Third Quarter 2026 Earnings Release Date and Conference Call Information","url":"https://stock-news.laohu8.com/highlight/detail?id=2672828457","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672828457?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:05","pubTimestamp":1790798700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nTUA582NB3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NETL","ADC","BK4231","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671320189","title":"Press Release: Avacta Group Plc: Interim Results for the Six Months to June 30, 2026, and Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2671320189","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671320189?lang=en_us&edition=fundamental","pubTime":"2026-09-30 20:00","pubTimestamp":1790769600,"startTime":"0","endTime":"0","summary":"LONDON and PHILADELPHIA, Sept. 30, 2026  -- Avacta Therapeutics , a life sciences company developing innovative, targeted oncology drugs, today publishes its unaudited interim results for the six months ended June 30, 2026 .H1 highlights and post periodResearch & developmentNext Generation pre|CISION pipeline-- AVA6103 . -- Preliminary preclinical and clinical data with AVA6103 have been. presented recently. Data reported in the Phase 1a trial in. patients with select solid tumors demonstrate proof of mechanism. demonstrates a clean safety profile through the first three. dose levels, including a payload dose level 50% higher than. -- The comparison of the preclinical modeled pharmacokinetic.  data and clinical trial PK data demonstrates an. exceptional alignment through the first 3 dose levels with. controlled release of exatecan evident in patients for days. -- The first head-to-head preclinical comparison of AVA6103 and. Enhertu, a marketed antibody drug conjugate  that targets. HER","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4567","MTD","BK4022","LU2413666426.HKD","BK4123","BK4585","LU2413666699.HKD","LU1093756168.USD","LU2211817866.USD","KBWY","IE00BFXG0V08.USD","LU1093756325.SGD","BK4218","LU1721428933.USD","PDC","BK4181","BK4231","IE00BYQQ9H92.USD","R","BK4588","AVCTF","NETL","BK4232","LU0347712357.USD","IE00B5TLWC47.USD","BK4080","IND","PK","BK4548","ADC","BK4121","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671220428","title":"Pyxis Oncology Announces Pricing of Up to $282.6 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2671220428","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671220428?lang=en_us&edition=fundamental","pubTime":"2026-09-30 13:11","pubTimestamp":1790745060,"startTime":"0","endTime":"0","summary":"BOSTON, Sept.  30, 2026 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced the pr","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/30/3371511/0/en/pyxis-oncology-announces-pricing-of-up-to-282-6-million-public-offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYXS","ADC","BK4080","BK4139","BK4231","NETL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671119742","title":"Sutro Biopharma Appoints Lucas Donigian as Senior Vice President, Business Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2671119742","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671119742?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:00","pubTimestamp":1790683200,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Sept.  29, 2026 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-forma","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/29/3370766/0/en/sutro-biopharma-appoints-lucas-donigian-as-senior-vice-president-business-development.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4080","BK4231","ADC","NETL","STRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670231728","title":"Press Release: Xilio Therapeutics Appoints Yariv J. Houvras, M.D., Ph.D. as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2670231728","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670231728?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:30","pubTimestamp":1790595000,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","BK4231","LENZ","BK4080","BK4007","BK4139","BK4539","XLO","NETL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197962641","title":"Sichuan Biokin Pharmaceutical Receives Clinical Trial Approval for Injectable BL-M12D1 (ADC)","url":"https://stock-news.laohu8.com/highlight/detail?id=1197962641","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197962641?lang=en_us&edition=fundamental","pubTime":"2026-09-27 19:26","pubTimestamp":1790508369,"startTime":"0","endTime":"0","summary":"Sichuan Biokin Pharmaceutical Co.,Ltd. (688506.SH) has announced that the company recently received the official Drug Clinical Trial Approval Notice issued by the National Medical Products...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","BMED","MDTX","NETL","PSYK","BK0239","ADC","IBBQ","IBBJ","BK4231","91194","688506"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670482204","title":"Avacta Group plc: The FOCUS-01 Clinical Trial Design and Preclinical Data Further Demonstrate the Potential of AVA6103 at AACR Conference on Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2670482204","media":"GlobeNewswire","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670482204?lang=en_us&edition=fundamental","pubTime":"2026-09-25 14:00","pubTimestamp":1790316000,"startTime":"0","endTime":"0","summary":"LONDON and PHILADELPHIA, Sept.  25, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, the \"Company\", \"Avacta\"), a life sciences company developing innovative, targeted oncology drugs, today ann","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/25/3368853/0/en/avacta-group-plc-the-focus-01-clinical-trial-design-and-preclinical-data-further-demonstrate-the-potential-of-ava6103-at-aacr-conference-on-pancreatic-cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0828238088.HKD","MTD","BK4108","BK4509","LU1023057109.AUD","IE00B5TLWC47.USD","BK4585","LU0347712357.USD","NETL","BK4218","BK4565","BK4548","LU2211817866.USD","BK4588","BK4123","BK4571","IE00BYQNZ168.SGD","BK4567","IE00BYQQ9H92.USD","BK4533","BK4526","LU0269904917.USD","BK4121","PDX","BK4181","LU0359202008.SGD","IE00BFXG0V08.USD","KBWY","LU2413666699.HKD","LU0359201612.USD","LU2039709279.SGD","ADC","BK4552","IE00B12V2V27.USD","LU0456842615.SGD","PDC","LU0509642566.USD","LU1721428933.USD","PK","TME","BK4531","BK4563","LU2413666426.HKD","BK4080","BK4231","01698","IE00BYTNYN87.SGD","SG9999011746.SGD","LU1093756168.USD","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669487649","title":"Agree Realty Currently Down 11 Consecutive Days, on Pace for Record Losing Streak","url":"https://stock-news.laohu8.com/highlight/detail?id=2669487649","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669487649?lang=en_us&edition=fundamental","pubTime":"2026-09-23 23:45","pubTimestamp":1790178300,"startTime":"0","endTime":"0","summary":"Agree Realty Corporation  is currently at $66.74, down $0.58 or 0.87%--Would be lowest close since July 23, 2024, when it closed at $66.69--On pace for largest percent decrease since Sept. 16, 2026, when it fell 2.24%--Currently down 12 of the past 13 days--Currently down 11 consecutive days; down 8.31% over this period--Longest losing streak on record --Worst 11 day stretch since the 11 days ending Aug. 12, 2026, when it fell 8.33%--Down 7.63% month-to-date; on pace for worst month since Dec. 2024, when it fell 8.27%--Down 7.35% year-to-date--Down 18.54% from its all-time closing high of $81.92 on March 3, 2026--Down 5.58% from 52 weeks ago , when it closed at $70.68--Down 18.54% from its 52-week closing high of $81.92 on March 3, 2026--Would be a new 52-week closing low--Traded as low as $66.50; lowest intraday level since July 23, 2024, when it hit $65.98--Down 1.22% at today's intraday lowAll data as of 11:43:11 AM ETSource: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NETL","BK4231","BK4080","ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669010095","title":"Agree Realty Chief Growth Officer Craig Erlich Acquires $67,550 Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2669010095","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669010095?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:00","pubTimestamp":1790161256,"startTime":"0","endTime":"0","summary":"Agree Realty Chief Growth Officer Craig Erlich acquires $67,550 common sharesAgree Realty Chief Growth Officer Craig Erlich bought 1,000 common shares at USD 67.55 each.Directly held common shares ros","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDLbJql8z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Agree Realty Chief Growth Officer Craig Erlich Acquires $67,550 Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","BK4231","NETL","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669179227","title":"Analysts Offer Insights on Real Estate Companies: GPT Group (OtherGPTGF) and Agree Realty (ADC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669179227","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669179227?lang=en_us&edition=fundamental","pubTime":"2026-09-23 10:10","pubTimestamp":1790129405,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Real Estate sector as 2 analysts just weighed in on GPT Group (GPTGF) and Agree Realty (ADC) with bulli...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-real-estate-companies-gpt-group-othergptgf-and-agree-realty-adc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-real-estate-companies-gpt-group-othergptgf-and-agree-realty-adc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4080","ADC","GPTGF","BK4160","GPT","NETL","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669122856","title":"Agree Realty Subsidiary Issues USD 400 Million 5.65% Notes Due 2036, Backed by Parent Guarantee","url":"https://stock-news.laohu8.com/highlight/detail?id=2669122856","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669122856?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:06","pubTimestamp":1790107607,"startTime":"0","endTime":"0","summary":"Agree Realty subsidiary issues USD 400 million 5.65% notes due 2036, backed by parent guaranteeAgree Realty priced a USD 400 million offering of 5.650% Notes due 2036 through its Agree Limited Partner","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL8zbtVf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NETL","BK4231","BK4080","ADC"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.agreerealty.com","stockEarnings":[{"period":"1week","weight":-0.0247},{"period":"1month","weight":-0.1027},{"period":"3month","weight":-0.163},{"period":"6month","weight":-0.1664},{"period":"1year","weight":-0.0752},{"period":"ytd","weight":-0.0954}],"compareEarnings":[{"period":"1week","weight":0.0191},{"period":"1month","weight":0.0091},{"period":"3month","weight":0.0339},{"period":"6month","weight":0.1439},{"period":"1year","weight":0.1616},{"period":"ytd","weight":0.1398}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Agree Realty Corporation (the Company), a Maryland corporation, is a fully integrated real estate investment trust (REIT) primarily focused on the ownership, acquisition, development and management of retail properties net leased to industry leading tenants. The Company was founded in 1971 by its current Executive Chairman, Richard Agree, and its common stock was listed on the New York Stock Exchange in 1994. As of March 31, 2024, the Company owned 2,161 properties, with a total gross leasable area (GLA) of approximately 44.9 million square feet.","yearOnYearQuotes":[{"month":1,"riseRate":0.59375,"avgChangeRate":-0.003579},{"month":2,"riseRate":0.46875,"avgChangeRate":0.002186},{"month":3,"riseRate":0.5625,"avgChangeRate":0.012831},{"month":4,"riseRate":0.59375,"avgChangeRate":0.003425},{"month":5,"riseRate":0.484848,"avgChangeRate":0.013996},{"month":6,"riseRate":0.666667,"avgChangeRate":0.010466},{"month":7,"riseRate":0.666667,"avgChangeRate":0.022977},{"month":8,"riseRate":0.454545,"avgChangeRate":-0.000027},{"month":9,"riseRate":0.454545,"avgChangeRate":-0.008411},{"month":10,"riseRate":0.545455,"avgChangeRate":-0.001077},{"month":11,"riseRate":0.65625,"avgChangeRate":0.003584},{"month":12,"riseRate":0.46875,"avgChangeRate":0.00994}],"exchange":"NYSE","name":"Agree","nameEN":"Agree"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Agree(ADC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Agree(ADC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Agree,ADC,Agree股票,Agree股票老虎,Agree股票老虎国际,Agree行情,Agree股票行情,Agree股价,Agree股市,Agree股票价格,Agree股票交易,Agree股票购买,Agree股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Agree(ADC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Agree(ADC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}